{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:48:09Z","timestamp":1761598089320,"version":"3.37.3"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471122"],"award-info":[{"award-number":["31471122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,9,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Angiogenesis is tightly linked to inflammation. Cytokines of\ninterleukin 1 (IL-1) family are key mediators in modulating inflammatory responses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, we examined the role of IL-38, a member of the IL-1 family, in\nmediating inflammation-induced angiogenesis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results showed that the angiogenesis was attenuated by topical\nadministration of IL-38 to the injured corneas in a mouse model of alkali-induced corneal\nneovascularization (CNV). Further study showed that the expression of inflammatory\ncytokines TNF-\u03b1, IL-6, IL-8 and IL-1\u03b2 was decreased in the IL-38-treated corneas.\nMoreover, the angiogenic activities including the proliferation, migration and tube\nformation of human retinal endothelial cells were reduced by IL-38 treatment in vitro.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The data indicate that IL-38 modulates inflammation-induced\nangiogenesis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524019666190627122655","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T08:59:02Z","timestamp":1561625942000},"page":"589-596","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Effect of Interleukin 38 on Inflammation-induced Corneal Neovascularization"],"prefix":"10.2174","volume":"19","author":[{"given":"Jiangli","family":"Zhu","sequence":"first","affiliation":[{"name":"The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Guangdong Science and Technology Library (Guangdong Institute of Scientific and Technical Information and Development Strategy), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangling","family":"Liu","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eryan","family":"Kong","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao B.","family":"Su","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, Henan, 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","volume":"6","author":"Epstein R.J.","year":"1987","unstructured":"Epstein R.J.; Stulting R.D.; Hendricks R.L.; Harris D.M.; Corneal neovascularization. Pathogenesis and inhibition. Cornea 1987,6(4),250-257","journal-title":"Cornea"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/10454411950060030501","volume":"6","author":"Polverini P J","year":"1995","unstructured":"Polverini P J; The pathophysiology of angiogenesis. Critical\nreviews in oral biology and medicine: An official publication of\nthe American Association of Oral Biologists 1995,6,230-247","journal-title":"An official publication of\nthe American Association of Oral Biologists"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1002\/jcb.26088","volume":"118","author":"Karizbodagh M.P.","year":"2017","unstructured":"Karizbodagh M.P.; Rashidi B.; Sahebkar A.; Masoudifar A.; Mirzaei H.; Implantation Window and Angiogenesis. J Cell Biochem 2017,118(12),4141-4151","journal-title":"J Cell Biochem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/jcp.26049","volume":"233","author":"Mashreghi M.","year":"2018","unstructured":"Mashreghi M.; Azarpara H.; Bazaz M.R.; Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. J Cell Physiol 2018,233(4),2949-2965","journal-title":"J Cell Physiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"Folkman J.","year":"2007","unstructured":"Folkman J.; Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 2007,6(4),273-286","journal-title":"Nat Rev Drug Discov"},{"key":"ref=6","first-page":"439","volume":"40","author":"Jang Y.J.","year":"2007","unstructured":"Jang Y.J.; Kim D.S.; Jeon O.H.; Kim D.S.; Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells. J Biochem Mol Biol 2007,40(3),439-443","journal-title":"J Biochem Mol Biol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","volume":"7","author":"Biswas P.S.","year":"2005","unstructured":"Biswas P.S.; Rouse B.T.; Early events in HSV keratitis--setting the stage for a blinding disease. Microbes Infect 2005,7(4),799-810","journal-title":"Microbes Infect"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"Lee P.","year":"1998","unstructured":"Lee P.; Wang C.C.; Adamis A.P.; Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998,43(3),245-269","journal-title":"Surv Ophthalmol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/jcp.26029","volume":"233","author":"Hashemi Goradel N.","year":"2018","unstructured":"Hashemi Goradel N.; Ghiyami-Hour F.; Jahangiri S.; Nanoparticles as new tools for inhibition of cancer angiogenesis. J Cell Physiol 2018,233(4),2902-2910","journal-title":"J Cell Physiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.biopha.2017.01.161","volume":"89","author":"Rashidi B","year":"2017","unstructured":"Rashidi B; Malekzadeh M; Goodarzi M; Masoudifar A; Mirzaei H; Green tea and its anti-angiogenesis effects. Biomedicine"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.acc.2017.06.004","volume":"82","author":"Mirzaei H.","year":"2017","unstructured":"Mirzaei H.; Ferns G.A.; Avan A.; Mobarhan M.G.; Cytokines and MicroRNA in Coronary Artery Disease. Adv Clin Chem 2017,82,47-70","journal-title":"Adv Clin Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0092-8674(00)81810-3","volume":"87","author":"Folkman J.","year":"1996","unstructured":"Folkman J.; D\u2019Amore P.A.; Blood vessel formation: what is its molecular basis? Cell 1996,87(7),1153-1155","journal-title":"Cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","volume":"27","author":"Chung A.S.","year":"2011","unstructured":"Chung A.S.; Ferrara N.; Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 2011,27,563-584","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=14","first-page":"624","volume":"51","author":"Sholley M.M.","year":"1984","unstructured":"Sholley M.M.; Ferguson G.P.; Seibel H.R.; Montour J.L.; Wilson J.D.; Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984,51(6),624-634","journal-title":"Lab Invest"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","volume":"96","author":"Kamba T.","year":"2007","unstructured":"Kamba T.; McDonald D.M.; Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007,96(12),1788-1795","journal-title":"Br J Cancer"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1073\/pnas.0437939100","volume":"100","author":"Voronov E.","year":"2003","unstructured":"Voronov E.; Shouval D.S.; Krelin Y.; IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003,100(5),2645-2650","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jso.21245","volume":"99","author":"Matsuo Y.","year":"2009","unstructured":"Matsuo Y.; Sawai H.; Ma J.; IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells\u2019 potential for liver metastasis. J Surg Oncol 2009,99(6),361-367","journal-title":"J Surg Oncol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","volume":"167","author":"Park C.C.","year":"2001","unstructured":"Park C.C.; Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001,167,1644-1653","journal-title":"J Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","volume":"114","author":"Choi Y.S.","year":"2009","unstructured":"Choi Y.S.; Choi H.J.; Min J.K.; Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production. Blood 2009,114(14),3117-3126","journal-title":"Blood"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"20597","DOI":"10.1074\/jbc.M010095200","volume":"276","author":"Lin H.","year":"2001","unstructured":"Lin H.; Ho A.S.; Haley-Vicente D.; Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 2001,276(23),20597-20602","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/107999001753289505","volume":"21","author":"Bensen J.T.","year":"2001","unstructured":"Bensen J.T.; Dawson P.A.; Mychaleckyj J.C.; Bowden D.W.; Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J Interfer Cytokine Res 2001,21,899-904","journal-title":"J Interfer Cytokine Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","volume":"275","author":"Kumar S.","year":"2000","unstructured":"Kumar S.; McDonnell P.C.; Lehr R.; Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000,275(14),10308-10314","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.1121534109","volume":"109","author":"van de Veerdonk F.L.","year":"2012","unstructured":"van de Veerdonk F.L.; Stoeckman A.K.; Wu G.; IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA 2012,109(8),3001-3005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/art.39328","volume":"67","author":"Rudloff I.","year":"2015","unstructured":"Rudloff I.; Godsell J.; Nold-Petry C.A.; Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus. Arthritis Rheumatol 2015,67(12),3219-3225","journal-title":"Arthritis Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","volume":"123","author":"Dehghan A.","year":"2011","unstructured":"Dehghan A.; Dupuis J.; Barbalic M.; Meta-analysis of genome-wide association studies in >80000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011,123(7),731-738","journal-title":"Circulation"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/art.21928","volume":"54","author":"Rahman P.","year":"2006","unstructured":"Rahman P.; Sun S.; Peddle L.; Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006,54(7),2321-2325","journal-title":"Arthritis Rheum"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/ard.2005.046847","volume":"65","author":"Chou C.T.","year":"2006","unstructured":"Chou C.T.; Timms A.E.; Wei J.C.; Tsai W.C.; Wordsworth B.P.; Brown M.A.; Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann Rheum Dis 2006,65(8),1106-1109","journal-title":"Ann Rheum Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1744-313X.2009.00889.x","volume":"37","author":"Guo Z.S.","year":"2010","unstructured":"Guo Z.S.; Li C.; Lin Z.M.; Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population. Int J Immunogenet 2010,37(1),33-37","journal-title":"Int J Immunogenet"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","volume":"71","author":"Monnet D.","year":"2012","unstructured":"Monnet D.; Kadi A.; Izac B.; Association between the IL-1 family gene cluster and spondyloarthritis. Ann Rheum Dis 2012,71(6),885-890","journal-title":"Ann Rheum Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jbspin.2011.06.010","volume":"79","author":"Lea W.I.","year":"2012","unstructured":"Lea W.I.; Lee Y.H.; The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint, Bone, Spine. Revue du Rhumatisme 2012,79,370-374","journal-title":"Revue du Rhumatisme"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.12644","volume":"181","author":"Ciccia F.","year":"2015","unstructured":"Ciccia F.; Accardo-Palumbo A.; Alessandro R.; Interleukin-36\u03b1 axis is modulated in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol 2015,181(2),230-238","journal-title":"Clin Exp Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"Liang C.C.","year":"2007","unstructured":"Liang C.C.; Park A.Y.; Guan J.L.; In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007,2(2),329-333","journal-title":"Nat Protoc"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.intimp.2006.07.003","volume":"6","author":"Lin C.M.","year":"2006","unstructured":"Lin C.M.; Chang H.; Chen Y.H.; Li S.Y.; Wu I.H.; Chiu J.H.; Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 2006,6(11),1690-1698","journal-title":"Int Immunopharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jvs.2011.07.072","volume":"55","author":"Sachdev U.","year":"2012","unstructured":"Sachdev U.; Cui X.; Hong G.; High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury. J Vasc Surg 2012,55(1),180-191","journal-title":"J Vasc Surg"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"Carmeliet P.","year":"2011","unstructured":"Carmeliet P.; Jain R.K.; Molecular mechanisms and clinical applications of angiogenesis. Nature 2011,473(7347),298-307","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0093-7754(01)90021-1","volume":"28","author":"Folkman J.","year":"2001","unstructured":"Folkman J.; Angiogenesis-dependent diseases. Semin Oncol 2001,28(6),536-542","journal-title":"Semin Oncol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1566524033479465","volume":"3","author":"Folkman J.","year":"2003","unstructured":"Folkman J.; Fundamental concepts of the angiogenic process. Curr Mol Med 2003,3(7),643-651","journal-title":"Curr Mol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.yjmcc.2004.01.006","volume":"36","author":"Amano K.","year":"2004","unstructured":"Amano K.; Okigaki M.; Adachi Y.; Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 2004,36(4),469-480","journal-title":"J Mol Cell Cardiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/art.10546","volume":"46","author":"Coxon A.","year":"2002","unstructured":"Coxon A.; Bolon B.; Estrada J.; Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum 2002,46(10),2604-2612","journal-title":"Arthritis Rheum"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imr.12612","volume":"281","author":"van de Veerdonk F.L.","year":"2018","unstructured":"van de Veerdonk F.L.; de Graaf D.M.; Joosten L.A.; Dinarello C.A.; Biology of IL-38 and its role in disease. Immunol Rev 2018,281(1),191-196","journal-title":"Immunol Rev"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","volume":"281","author":"Bassoy E.Y.","year":"2018","unstructured":"Bassoy E.Y.; Towne J.E.; Gabay C.; Regulation and function of interleukin-36 cytokines. Immunol Rev 2018,281(1),169-178","journal-title":"Immunol Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2018.01462","volume":"9","author":"Xu W.D.","year":"2018","unstructured":"Xu W.D.; Huang A.F.; Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review. Front Immunol 2018,9,1462","journal-title":"Front Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1038\/s41598-017-03079-z","volume":"7","author":"Zhang J.","year":"2017","unstructured":"Zhang J.; Zhao R.; Chen J.; The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy. Sci Rep 2017,7(1),2756","journal-title":"Sci Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/srep16053","volume":"5","author":"Pan B.","year":"2015","unstructured":"Pan B.; Shen J.; Cao J.; Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer. Sci Rep 2015,5,16053","journal-title":"Sci Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","volume":"118","author":"Vigne S.","year":"2011","unstructured":"Vigne S.; Palmer G.; Lamacchia C.; IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011,118(22),5813-5823","journal-title":"Blood"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:48:22Z","timestamp":1573998502000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173038\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,9,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190627122655","relation":{},"ISSN":["1566-5240"],"issn-type":[{"type":"print","value":"1566-5240"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}